Non-Invasive Glucose Monitoring via PPG: Current State of the Art
**Non-invasive glucose monitoring through photoplethysmography remains one of the most pursued and most elusive goals in biosensing.** Despite decades...
- PPG & Signal Processing
Non-invasive glucose monitoring through photoplethysmography remains one of the most pursued and most elusive goals in biosensing. Despite decades of research and hundreds of published studies, no PPG-based glucose monitoring device has achieved FDA clearance or demonstrated clinical-grade accuracy in independent validation. Yet the prize is enormous: replacing painful fingerstick testing and expensive continuous glucose monitors (CGMs) for the estimated 537 million people worldwide living with diabetes would fundamentally transform disease management.
This article provides a rigorous technical review of the current approaches, the evidence supporting them, the fundamental limitations, and the realistic trajectory toward clinical viability. For foundational context on how PPG sensors work, see our introduction to PPG technology.
The Physiological Basis for PPG-Glucose Correlation
Understanding why PPG might contain glucose information requires examining the multiple pathways through which blood glucose affects the optical and hemodynamic properties that PPG measures.
Direct Optical Effects
Glucose absorbs near-infrared (NIR) light mainly in the first overtone (1550-1850 nm) and combination (2000-2500 nm) regions, which correspond to O-H and C-H bond vibrations (Amerov et al., 2004, doi:10.1366/0003702042336136). However, the absorption coefficients at physiological glucose concentrations (4-10 mmol/L) are extremely small relative to water absorption, which dominates tissue optical properties. At the shorter wavelengths used by standard PPG sensors (green ~530 nm, red ~660 nm, infrared ~940 nm), the direct optical effect of glucose is negligible, on the order of 10^-5 absorbance units, which is well below the noise floor of consumer-grade photodetectors.
This physical reality means that standard dual-wavelength PPG sensors (used for SpO2 measurement) cannot directly measure glucose through absorption spectroscopy. Any glucose-related information in conventional PPG signals must therefore come from indirect physiological effects.
Indirect Hemodynamic Effects
Glucose influences several hemodynamic parameters that do modulate the PPG waveform. In diabetes, reduced red-cell deformability and increased aggregation raise whole-blood viscosity (Cho et al., 2008, doi:10.1177/193229680800200622), which can affect pulse wave velocity and waveform morphology. Hyperglycemia induces endothelial dysfunction and alters vascular reactivity, changing the augmentation index and reflection wave characteristics visible in the PPG pulse contour. Insulin secretion in response to glucose loads causes vasodilation that alters peripheral perfusion and PPG amplitude.
These indirect effects form the basis of most PPG-glucose correlation studies. However, reported correlations are modest and confounded by numerous other factors that affect vascular tone.
Scattering Effects
Glucose alters the refractive index of the interstitial fluid surrounding cells. As glucose concentration increases, the refractive index mismatch between intracellular and extracellular fluid decreases, reducing light scattering (Maier et al., 1994; doi:10.1364/OL.19.002062). This "optical clearing" effect has been demonstrated in vitro and in tissue phantoms, but the magnitude at physiological glucose concentrations is small, typically producing less than 1% change in detected light intensity across the 70-400 mg/dL glucose range.
Machine Learning Approaches
The weakness of direct physical correlations has driven researchers toward data-driven machine learning approaches that attempt to extract glucose information from complex patterns across multiple PPG features.
Feature Engineering Methods
Traditional machine learning pipelines extract handcrafted features from the PPG waveform and use regression models to predict glucose. Commonly extracted features include:
- Temporal features: systolic peak amplitude, diastolic peak amplitude, pulse interval, systolic time, diastolic time, pulse width at half maximum
- Morphological features: augmentation index, inflection point area ratio, crest time ratio, large artery stiffness index
- Frequency features: spectral power in cardiac harmonics, spectral centroid, harmonic amplitude ratios
- Derivative features: first and second derivative peak amplitudes and ratios (a, b, c, d, e waves of the acceleration plethysmogram)
Deep Learning Approaches
Deep learning models can automatically learn feature representations from raw PPG signals, potentially capturing patterns that handcrafted features miss.
Convolutional neural networks (CNNs) have been applied to raw PPG waveforms and their spectrograms.
Recurrent architectures (LSTM, GRU) have been employed to capture temporal dynamics in PPG glucose prediction.
Transformer-based architectures represent the most recent approach, applying attention models to PPG signals or their spectrogram representations. However, the computational requirements of transformer models raise questions about deployment feasibility on resource-constrained wearable hardware.
Multi-Wavelength and Hybrid Approaches
Recognizing the limitations of standard dual-wavelength PPG, several research groups have explored expanded spectral approaches.
Multi-Spectral PPG
By using 5 or more LED wavelengths spanning from visible to near-infrared, multi-spectral PPG systems aim to capture wavelength-dependent glucose absorption features that are invisible at standard wavelengths. Caduff et al. (2009, doi:10.1016/j.bios.2009.02.001) developed a Multisensor combining dielectric and optical skin sensing with sensors for perturbing factors such as temperature, moisture and perfusion. In 10 patients with type 1 diabetes it reached a MARD of 18.0% on the first study visit, but 27.3% when the same model coefficients were applied to a second visit.
Rockley Photonics developed a silicon photonics-based sensing chip integrating multiple wavelengths in the 900-1700 nm range on a single die. Their approach targeted the glucose absorption features in the short-wave infrared (SWIR) that are inaccessible to conventional LED-based systems. Early publications reported encouraging in vitro results, but in vivo clinical validation data has not been published in peer-reviewed literature.
Raman Spectroscopy Augmentation
Raman spectroscopy provides molecular-specific fingerprints for glucose. Kang et al. (2020, doi:10.1126/sciadv.aay5206) reported the first direct observation of glucose Raman peaks from in vivo skin, with signal intensity tracking reference glucose in three live swine glucose-clamping experiments. The excitation laser and spectrometer components still present significant miniaturization and power consumption challenges for wearable integration.
PPG Combined with Bioimpedance
Combining PPG with bioelectrical impedance spectroscopy (BIS) provides complementary information about tissue composition and fluid distribution. Glucose affects interstitial fluid osmolarity and cellular hydration, producing measurable impedance changes. Multi-modal approaches may be necessary to achieve clinically useful accuracy.
Critical Methodological Concerns
The PPG-glucose literature is plagued by methodological issues that call many reported results into question. Understanding these concerns is essential for evaluating any claimed breakthrough.
The Meal Correlation Problem
Blood glucose follows a predictable temporal pattern after meals: rising for 30-60 minutes, peaking, then declining over 2-3 hours. Many confounders, including skin temperature, heart rate, blood pressure, and autonomic tone, follow similar postprandial patterns driven by digestion and insulin secretion rather than glucose itself. A machine learning model trained on data collected around meals can achieve apparently good glucose prediction by learning these temporal patterns without actually sensing glucose.
Subject-Specific Calibration
Many studies calibrate their models on a per-subject basis using the first portion of each subject's data, then evaluate on the remaining data. This inflates accuracy because the model learns the individual's glucose-PPG relationship, which varies substantially across people due to differences in skin pigmentation, subcutaneous fat thickness, vascular anatomy, and metabolic response patterns. For a practical consumer device, either frequent recalibration (defeating the purpose of non-invasive monitoring) or robust cross-subject generalization is required. Cross-subject performance is consistently 40-60% worse than within-subject performance across published studies.
Small Sample Sizes and Limited Demographics
Most PPG-glucose studies are small and are conducted in controlled laboratory settings with homogeneous populations, typically young, healthy adults with limited representation of darker skin tones, which significantly affects PPG signal quality and feature extraction. Generalization to the diverse population of diabetes patients, who tend to be older with comorbidities affecting peripheral perfusion, remains undemonstrated.
Regulatory and Clinical Pathway
The FDA classifies non-invasive glucose monitors as Class III medical devices requiring premarket approval (PMA) through clinical trials. The required accuracy thresholds, derived from the SpO2 estimation and CGM regulatory frameworks, are substantially higher than what current PPG-based systems achieve.
For a self-monitoring blood glucose (SMBG) replacement, the FDA expects at least 95% of paired readings within +/-15% of reference values for glucose above 75 mg/dL and within +/-15 mg/dL for glucose below 75 mg/dL. For CGM-class devices, MARD below 10% is the current standard set by devices like the Dexterity G7 (MARD 8.2%) and Abbott FreeStyle Libre 3 (MARD 7.9%).
No PPG-based approach has demonstrated MARD below 15% in a properly designed, sufficiently powered clinical study with independent validation. The gap between current performance and regulatory requirements remains significant.
The Path Forward
Several developments may incrementally improve PPG-based glucose estimation toward clinical utility.
Advanced Photonic Integration
Continued advances in silicon photonics may enable integration of SWIR wavelengths (1000-1700 nm) into wearable-compatible form factors. These wavelengths offer 10-100x stronger glucose absorption than visible/NIR bands. The key engineering challenges are miniaturizing the optical components while maintaining sufficient signal-to-noise ratio and managing the power consumption of longer-wavelength emitters.
Personalized Foundation Models
Large-scale pre-training on diverse PPG datasets followed by few-shot personalization could improve cross-subject generalization. Transfer learning approaches that adapt a general glucose estimation model to an individual using only a few calibration points may help, but this has not yet been shown in a properly powered study.
Trend Detection Rather Than Absolute Values
Rather than targeting absolute glucose values, some researchers argue that detecting glucose trends (rising, falling, stable) and threshold crossings (hypoglycemia alerts) may be achievable with current technology and clinically useful even without precise numerical accuracy. For trend detection, the relevant metric is sensitivity and specificity for directional changes rather than numerical MARD. Preliminary data suggests 75-85% accuracy for trend direction detection, which, if validated, could provide value as a screening tool complementing rather than replacing conventional monitoring.
Multi-Modal Sensor Fusion
The convergence of PPG with additional sensing modalities, including bioimpedance, skin conductance, temperature, and accelerometry, within modern wearable platforms provides richer input data. Multi-modal approaches consistently outperform PPG-only methods by 20-35% in MARD reduction. As wearable sensor integration advances, the combination of modalities may eventually close the accuracy gap, though this remains speculative.
Conclusion
Non-invasive glucose monitoring via PPG is a problem where the clinical need is immense but the physics are unfavorable. The direct optical signature of glucose at standard PPG wavelengths is too weak for reliable measurement, forcing reliance on indirect correlations that are confounded by numerous physiological variables. Machine learning approaches show promise in controlled settings but have not demonstrated the cross-subject generalization and accuracy required for clinical deployment.
The honest assessment of the field is that PPG alone is unlikely to achieve diagnostic-grade glucose monitoring. Multi-wavelength optical approaches extending into the SWIR range, combined with complementary sensing modalities, represent the most plausible path toward a wearable non-invasive glucose monitor. Researchers and engineers should approach claims of PPG-glucose accuracy with healthy skepticism, paying particular attention to study design, validation methodology, and independent replication.
For related work on extracting clinical biomarkers from PPG signals, see our guides on PPG signal processing algorithms and cardiovascular health assessment.
References
- Amerov AK, Chen J, Arnold MA. Molar absorptivities of glucose and other biological molecules in aqueous solutions over the first overtone and combination regions of the near-infrared spectrum. Applied Spectroscopy. 2004;58(10):1195-1204. https://doi.org/10.1366/0003702042336136
- Cho YI, Mooney MP, Cho DJ. Hemorheological disorders in diabetes mellitus. Journal of Diabetes Science and Technology. 2008;2(6):1130-1138. https://doi.org/10.1177/193229680800200622
- Maier JS, Walker SA, Fantini S, Franceschini MA, Gratton E. Possible correlation between blood glucose concentration and the reduced scattering coefficient of tissues in the near infrared. Optics Letters. 1994;19(24):2062-2064. https://doi.org/10.1364/OL.19.002062
- Caduff A, Talary MS, Mueller M, et al. Non-invasive glucose monitoring in patients with Type 1 diabetes: a Multisensor system combining sensors for dielectric and optical characterisation of skin. Biosensors and Bioelectronics. 2009;24(9):2778-2784. https://doi.org/10.1016/j.bios.2009.02.001
- Kang JW, Park YS, Chang H, et al. Direct observation of glucose fingerprint using in vivo Raman spectroscopy. Science Advances. 2020;6(4):eaay5206. https://doi.org/10.1126/sciadv.aay5206
Related articles
Abdominal PPG for Fetal Heart Rate Monitoring: Non-Invasive Prenatal Surveillance
**Fetal heart rate (FHR) monitoring is a cornerstone of prenatal care, yet current clinical methods remain cumbersome, intermittent, or invasive.** Ph...
Non-Invasive Intracranial Pressure Monitoring: Where PPG Fits and Where It Doesn’t
A careful look at PPG intracranial pressure monitoring, including why optical signals may reflect ICP, what studies show, and where clinical limits remain.
Non-Invasive Hemoglobin Monitoring: Can PPG Estimate Hb in Real Time?
Can a non invasive hemoglobin monitor estimate Hb in real time? Learn where pulse CO-oximetry and PPG help, where they fail, and how to validate them.
Remote Monitoring of Vital Signs with PPG: Platforms, Evidence, and FDA Status
PPG-based remote vital signs monitoring platforms reviewed. FDA-cleared devices, clinical evidence, and how remote monitoring improves patient outcomes.
PPG Perioperative Monitoring
Perioperative hemodynamic optimization, managing fluid balance, cardiac output, and vascular resistance during and after surgery, is central to reduci...